Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
RunaPharma from Ranst, company number BE0823524555, closed financial year 2025 with a result of € -1,293 after tax. For that financial year RunaPharma recorded a gross margin of € -659 and equity of € -18,060. Compared with financial year 2024, the result moved from € -2,388 to € -1,293. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 9, 2025.
€ -18,060
▼ € 1,293 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,293
▲ 46 % less loss than in 2024
Profit after tax over the fiscal year.
€ 189
▲ 23% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -38,060.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 139 | € -357 | € -1,856 | € -659 | ▲ € 1,197 |
| Profit after taxes | € 1 | € -845 | € -2,388 | € -1,293 | ▲ € 1,095 |
| Equity | € -13,534 | € -14,379 | € -16,767 | € -18,060 | ▼ € 1,293 |
| Total debts | € 14,576 | € 14,458 | € 16,922 | € 18,249 | ▲ 8% |
| Cash | € 1,043 | € 79 | € 154 | € 189 | ▲ 23% |
| Retained profit | € -33,534 | € -34,379 | € -36,767 | € -38,060 | ▼ € 1,293 |
| Balance sheet total | € 1,043 | € 79 | € 154 | € 189 | ▲ 23% |
Key figures of RunaPharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to RunaPharma?
What happened at RunaPharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,293. Source: NBB ↗
- New establishment in Ranst. KBO
- Start of the company according to the CBE. KBO
- Lodewijk Van der Auwera became a director. NBB
In short
From € 1 profit in 2022 to € 1,293 loss in 2025.
Best year ever: 2022, with € 1 profit.
A new publication or filing at RunaPharma? We notify you, reason included.
Follow RunaPharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind RunaPharma is Lodewijk Van der Auwera. Lodewijk Van der Auwera is also behind DOMEIN MARTINUS and ARCUS.
Directors
According to the 2025 annual accounts
since 2010
Establishments
Establishment units
Physical locations of this company
Kantonbaan 9
2520 Ranst
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0823.524.555
- VAT number
- BE 0823.524.555
- Registered office
- Kantonbaan 9, 2520 Ranst
- Names & denominations
- RunaPharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2010
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige technische testen en toetsen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering